Developing and Implementing a New Prison-Based Buprenorphine Treatment Program

• NCJ Number: 229990
• Journal: Journal of Offender Rehabilitation Volume: 49 Issue: 2 Dated: February - March 2010 Pages: 91-109
• Author(s): Timothy W. Kinlock; Michael S. Gordon; Robert P. Schwartz; Terrence T. Fitzgerald
• Date Published: February 2010
• Length: 19 pages
• Grant Number(s): R01DA021579
• Sponsoring Agency: National Institute on Drug Abuse
• Publication Format: Article
• Publication Type: Research (Applied/Empirical)
• Language: English
• Country: United States of America

Annotation

This article presents an overview of the first randomized clinical trial of a prison-based buprenorphine treatment program and describes the obstacles that were encountered during the process.

Abstract

Research suggests that buprenorphine treatment may be a promising intervention for incarcerated individuals with heroin addiction histories. However, its implementation varies from corrections-based methadone because of unique challenges regarding dosing, administration, and regulation. Describing the first randomized clinical trial of prison-initiated buprenorphine treatment in the United States, this article focuses on how these obstacles were overcome through collaboration among correctional, treatment, and research personnel. Building on the present authors' work in developing prison-based methadone treatment, and considering the lack of experience in implementing corrections-based buprenorphine programs in the United States, this article may serve as a guide for interested corrections officials, treatment providers, and researchers. References (Published Abstract)